Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.6 USD | +1.41% | -0.55% | -37.50% |
May. 13 | Transcript : Journey Medical Corporation, Q1 2024 Earnings Call, May 13, 2024 | |
May. 13 | Journey Medical Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Financials (USD)
Sales 2024 * | 56.82M | Sales 2025 * | 80.37M | Capitalization | 71.9M |
---|---|---|---|---|---|
Net income 2024 * | -17M | Net income 2025 * | -4M | EV / Sales 2024 * | 1.27 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 0.89 x |
P/E ratio 2024 * |
-3.85
x | P/E ratio 2025 * |
-15
x | Employees | 41 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 47.62% |
Latest transcript on Journey Medical Corporation
1 day | +1.41% | ||
1 week | -0.55% | ||
Current month | -2.44% | ||
1 month | +1.69% | ||
3 months | -1.37% | ||
6 months | -15.89% | ||
Current year | -37.50% |
Managers | Title | Age | Since |
---|---|---|---|
Claude Maraoui
FOU | Founder | 57 | 14-09-30 |
Joseph Benesch
DFI | Director of Finance/CFO | 57 | 21-10-31 |
Chief Tech/Sci/R&D Officer | - | 21-08-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 68 | 14-09-30 | |
Neil Herskowitz
BRD | Director/Board Member | 67 | 20-12-31 |
Miranda Toledano
BRD | Director/Board Member | 47 | 21-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 3.6 | +1.41% | 59,216 |
24-05-22 | 3.55 | +5.34% | 63,539 |
24-05-21 | 3.37 | -0.88% | 105,858 |
24-05-20 | 3.4 | -1.45% | 53,153 |
24-05-17 | 3.45 | -4.70% | 67,276 |
Delayed Quote Nasdaq, May 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-37.50% | 71.9M | |
+38.69% | 728B | |
+34.28% | 603B | |
-4.49% | 360B | |
+20.24% | 332B | |
+2.12% | 279B | |
+17.02% | 244B | |
+9.31% | 207B | |
-5.07% | 205B | |
-0.35% | 163B |
- Stock Market
- Equities
- DERM Stock